Clinical Trials in Philadelphia

Showing 11281-11300 of 20,904 trials

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

NCT02785250

T cell activating therapy DPX-Survivac, low dose oral cyclophosphamide, and IDO1 inhibitor epacadostat will be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the safety and potential immune-modulating activity of the combination of these agents.

Recurrent Epithelial Ovarian CancerRecurrent Fallopian Tube CancerRecurrent Peritoneal Cancer

ImmunoVaccine Technologies, Inc. (IMV Inc.)85 participantsStarted Apr 2016

Palo Alto, California, United States • Augusta, Georgia, United States • New York, New York, United States +6 more locations

COMPLETED< 1 mile

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

NCT02852252

The study objective is to collect prospective data on cancer patients who undergo surgery and intraoperative imaging. The registry will include (but not limited to) cancer type, stage, intraoperative challenges to the surgeon, usage and results of intraoperative imaging, and recurrence surveillance.

Bladder CancerGastric Cancer

University of Pennsylvania291 participantsStarted Jul 2016

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

NCT03084796

The purpose of this study is to evaluate the dose-response of different doses of CHF 5259 pMDI on lung function and other clinical outcomes, to identify the optimal dose(s) in terms of benefit/ risk ratio for further development in the target subject population.

COPDChronic Obstructive Pulmonary Disease

Chiesi Farmaceutici S.p.A.733 participantsStarted Jul 2017

Birmingham, Alabama, United States • Dothan, Alabama, United States • Montgomery, Alabama, United States +109 more locations

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

Find Trials by Condition in Philadelphia

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers

Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder

Prevention of Recurrence of Diverticulitis

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Efficacy and Safety of SPD503 in Combination With Psychostimulants

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery

Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease

Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)

Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)

Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®